We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 14

Countdown to the introduction of the new patent box regime

  • McDermott Will & Emery
  • -
  • United Kingdom
  • -
  • January 21 2013

From 1 April 2013, UK companies will be able to elect into a new regime that applies a lower rate of corporation tax to profits from qualifying

Breakthrough: Europe gets the European Patent Court

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • June 29 2012

Europe has debated establishing a single EU Patent System for more than four decades

Drug formulation patent found to be invalid in the United Kingdom but valid in other jurisdictions

  • McDermott Will & Emery
  • -
  • United Kingdom
  • -
  • April 30 2012

Mr Justice Arnold’s decision in Teva and others v Astrazeneca AB 2012 EWHC 655 (Pat) invalidated Astrazeneca’s patent for a sustained release formulation of the anti-psychotic drug quetiapine in the United Kingdom, on the grounds of obviousness, just days after the same patent was found to be valid in the Netherlands

The extent of patent coverage in offshore waters: a comparison

  • McDermott Will & Emery
  • -
  • South Africa, United Kingdom, USA
  • -
  • April 5 2012

Patents are often said to be defined by their claims and, as such, are analogous in the parlance of real property to the “metes and bounds” of a deed to real property

Navigating the evolving regulation and commercialization of stem cell research

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • March 22 2012

Interested parties that can successfully navigate the evolving regulation of stem cell research stand to gain significant scientific and commercial advantage

EU patent package receives a mixed reaction

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • February 29 2012

The Legal Affairs Committee of the European Parliament has backed proposals for the new “EU patent package”, consisting of a unitary patent, language regime, and unified patent court

UK Supreme Court steps into line with Europe, but rejects U.S. approach

  • McDermott Will & Emery
  • -
  • European Union, United Kingdom, USA
  • -
  • November 30 2011

The UK’s highest court recently considered the provisions of the European Patent Convention (EPC) centering on the “susceptible of industrial application” requirement in the context of a patent describing a DNA sequence for a new protein, Neutrokine-α, which was a member of a group of similar proteins known as the TNF ligand superfamily

Is EU-wide patent protection on the horizon?

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • March 31 2011

Reform of the current European patent protection systemwhereby European patents are actually a bundle of national patents that must be enforced separately in each European jurisdictionhas been on the political agenda for some 30 years

ECJ declares proposed European and Community patents court unconstitutional

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • March 15 2011

On 8 March 2011, the European Court of Justice handed down its Opinion No 109, in which it found that the proposed agreement on the community patents court is not compatible with the provisions of the European Union Treaties

Cephalon Inc v Orchid Europe Ltd: generics, interim injunctions and “clearing the way”

  • McDermott Will & Emery
  • -
  • United Kingdom
  • -
  • February 28 2011

The High Court of England and Wales has refused to grant an interim injunction to Cephalon against Orchid Europe Ltd's generic version of Cephalon's patented sleeping disorders drug, modafinil

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy